Stay updated on CAR T vs. PD-1 KO for NSCLC Clinical Trial
Sign up to get notified when there's something new on the CAR T vs. PD-1 KO for NSCLC Clinical Trial page.

Latest updates to the CAR T vs. PD-1 KO for NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page presents details for a Phase 1/2 study of anti-MUC1 CAR T cells and PD-1 knockout engineered T cells for advanced non-small cell lung cancer, including study arms, participant eligibility, recruiting locations, and measured outcomes.SummaryDifference60%

- Check11 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the usual study details, indicating the record is currently inaccessible.SummaryDifference20%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a backend or template update. This change does not affect the study details or their presentation.SummaryDifference0.1%

Stay in the know with updates to CAR T vs. PD-1 KO for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR T vs. PD-1 KO for NSCLC Clinical Trial page.